Skip to main content
. Author manuscript; available in PMC: 2011 Jan 12.
Published in final edited form as: Blood Cells Mol Dis. 2010 Nov 26;46(1):66–72. doi: 10.1016/j.bcmd.2010.10.011

Table 8.

DXA Z-scores of adults.

Years following initiation of imiglucerase Baseline DXA ≤−1 (n=68 patients, 253 assessments)
Predicted DXA Z-score Lower 95% confidence interval Upper 95% confidence interval
Baseline (−1 to<0) −1.82 −2.00 −1.63
0 to<1 −1.73 −1.89 −1.57
1 to <2 −1.65 −1.81 −1.49
2 to <3 −1.58 −1.74 −1.42
3 to <4 −1.51 −1.68 −1.35
4 to <5 −1.47 −1.64 −1.30
5 to <6 −1.42 −1.60 −1.24
6 to <7 −1.39 −1.58 −1.19
7 to <8 −1.35 −1.57 −1.13
8 to <9 −1.32 −1.57 −1.06
9 to <10 −1.30 −1.57 −1.04

DXA Z-scores of patients with 2 or more measurements from a non-linear mixed model in adults (ages≥30 years to ≤50 years).

HHS Vulnerability Disclosure